28 completed. 28 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 28 | Completed 28 |
| Phase 2 | 9 | Completed 9 |
Follow Atrophy: new trials by email Literature Review of Atrophy trials Research Report on Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis. IMM01-STEM - Muscle Atrophy | Phase 1 / Phase 2 | Completed | Immunis, Inc. | 13 | 2022-09-13 | 2026-09-09 |
| Electrical Stimulation for Critically Ill Covid-19 Patients Electrical Stimulation, Electrical Stimulation - Sham - Covid19, Muscle Atrophy | Phase 1 | Completed | Baylor College of Medicine | 19 | 2020-12-22 | 2023-02-16 |
| Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. PF-06946860 - Cachexia, Non-Small-Cell Lung Cancer | Phase 1 | Completed | Pfizer | 11 | 2020-11-17 | 2023-12-14 |
| Effect of a Ghrelin Receptor Agonist on Muscle and Bone Anamorelin Hydrochloride, Placebo - Sarcopenia, Osteopenia | Phase 1 | Completed | Tufts University | 32 | 2019-12-05 | 2024-03-27 |
| Leucine Supplementation in Sarcopenic Older Individuals Leucine, Placebo - Frail Elderly Syndrome, Sarcopenia | Phase 1 | Completed | University of Valencia | 59 | 2019-02-01 | 2020-04-06 |
| Effects of Chicken Extract and Collagen on Mobility Collagen hydrolysate and chicken extract - Knee Osteoarthritis, Muscle Loss | Phase 1 | Completed | Shan May Yong | 160 | 2018-12-01 | 2020-07-29 |
| Dose-response Effect of Dietary Nitrate on Muscle Function in Older Individuals Beet root juice - Aging, Sarcopenia | Phase 1 | Completed | Indiana University | 13 | 2018-09-01 | 2024-07-29 |
| The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity Oxytocin nasal spray, Placebo nasal spray - Obesity, Sarcopenic Obesity | Phase 1 / Phase 2 | Completed | Sara Espinoza | 23 | 2017-09-22 | 2021-10-22 |
| Nutritional Intervention for Age-related Muscular Function and Strength Losses-Study 2 Placebo, HMB plus Vitamin D, Non-Exercise - Sarcopenia | Phase 1 | Completed | Metabolic Technologies Inc. | 238 | 2014-08-01 | 2019-02-11 |
| Metformin and Muscle in Insulin-resistant Older Veterans metformin, placebo - Prediabetes | Phase 1 / Phase 2 | Completed | VA Office of Research and Development | 120 | 2014-04-08 | 2020-02-11 |
| Omega-3 Fatty Acids to Combat Sarcopenia Omega-3 fatty acids - Sarcopenia | Phase 1 | Completed | Mayo Clinic | 24 | 2014-03-01 | 2015-12-24 |
| Preventive Effect of Proprioceptive Stimulation on Muscle Atrophy proprioceptive stimulation - Knee Arthritis | Phase 1 / Phase 2 | Completed | University Hospital, Lille | 34 | 2012-03-01 | 2015-04-09 |
| Cedar Honey in Oral Lichen Planus orally administered cedar honey - Erosive and Atrophic Oral Lichen Planus | Phase 1 / Phase 2 | Completed | Mashhad University of Medical Sciences | 36 | 2011-09-01 | 2013-11-01 |
| Study of Inactivity on Metabolism of Elderly Muscles Step reduction - Sarcopenia | Phase 1 | Completed | McMaster University | 10 | 2011-09-01 | 2020-02-25 |
| 31P MRS Ischaemic Exercise Optimisation and COPD MRI scan - Atrophy, Muscular | Phase 1 | Completed | GlaxoSmithKline | 75 | 2010-04-01 | 2013-07-01 |
| A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days Placebo, SRT2104 - Atrophy, Muscular | Phase 1 | Completed | GlaxoSmithKline | 24 | 2009-10-01 | 2017-06-16 |
| A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women ACE-031, Placebo - Muscular Atrophy | Phase 1 | Completed | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 70 | 2009-08-01 | 2011-03-23 |
| Nutritional and Contractile Regulation of Muscle Growth Rapamycin, Amino acid supplementation, Low-intensity resistance exercise - Sarcopenia | Phase 1 | Completed | The University of Texas Medical Branch, Galveston | 144 | 2009-04-01 | 2017-05-04 |
| Nutrition and Exercise for Sarcopenia Amino acids, Exercise - Sarcopenia | Phase 1 | Completed | The University of Texas Medical Branch, Galveston | 108 | 2009-03-01 | 2016-12-12 |
| Nutritional Intervention for Age-related Muscular Function and Strength Losses Placebo, Vitamin D, Beta-hydroxy-Beta-methylbutyrate - Muscle Strength, Sarcopenia | Phase 1 | Completed | Metabolic Technologies Inc. | 76 | 2008-11-01 | 2014-09-17 |
Showing 20 of 28. Sign in to see all of them.
Sarcopenia (16) · Muscular Atrophy (10) · Insulin Resistance (2) · Motor Activity (2) · Anorexia (1) · Bone Diseases, Metabolic (1) · COVID-19 (1) · Cachexia (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Fatigue (1) · Frailty (1) · Hypertrophy (1) · Lichen Planus, Oral (1)
Pathological Conditions, Anatomical (28) · Pathological Conditions, Signs and Symptoms (28) · Neurologic Manifestations (27) · Signs and Symptoms (27) · Nervous System Diseases (26) · Neuromuscular Manifestations (26) · Muscular Atrophy (16) · Nutritional and Metabolic Diseases (4) · Behavior (3) · Metabolic Diseases (3) · Musculoskeletal Diseases (3) · Body Weight (2) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2)
ACVR2B protein, human (2) · Cholecalciferol (2) · Exercise (2) · Leucine (2) · Nitroprusside (2) · Vitamin D (2) · Amino Acids (1) · Amino Acids, Essential (1) · Electric Stimulation (1) · Fatty Acids, Omega-3 (1) · Insulin (1) · Magnetic Resonance Spectroscopy (1) · Metformin (1) · Mometasone Furoate (1) · Nortriptyline (1)
The University of Texas Medical Branch, Galveston (3) · Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA (2) · GlaxoSmithKline (2) · Maastricht University Medical Center (2) · Metabolic Technologies Inc. (2) · Baylor College of Medicine (1) · Immunis, Inc. (1) · Indiana University (1) · Mashhad University of Medical Sciences (1) · Mayo Clinic (1) · McMaster University (1) · Nutricia Research (1) · Pfizer (1) · Sara Espinoza (1) · Shan May Yong (1)
United States (15) · Canada (3) · Netherlands (3) · United Kingdom (2) · France (1) · Germany (1) · Iran (1) · Spain (1) · Taiwan (1)
Luc JC van Loon, PhD (2) · Andrew R Coggan, PhD (1) · Bess Dawson-Hughes, MD (1) · Blake Rasmussen, PhD (1) · Elena Volpi, MD, PhD (1) · Elena Volpi, MD,PhD (1) · Hsin-Nung Shih, MD (1) · Ian R Lanza, PhD (1) · Johannes Gassmueller, M.D. (1) · John A Rathmacher, PhD (1) · John A. Rathmacher, Ph.D. (1) · Majid Sanatkhani, Assistant Professor (1) · Michael O. Thorner, MBBS, DSc, (1) · Omar Cauli, MD, PhD (1)
PMID 16030064, PMID 16614412, PMID 16896165, PMID 17351147, PMID 18323467, PMID 18342407, PMID 18713956, PMID 18787087, PMID 20876843, PMID 22338078, PMID 15798081, PMID 16365098, PMID 16464955, PMID 16705054, PMID 16868746, PMID 16873412, PMID 17478528, PMID 17569770, PMID 17885021, PMID 18056791, PMID 18090658, PMID 18236467, PMID 18317375, PMID 18347658, PMID 18403916, PMID 18535123, PMID 18827171, PMID 18845784, PMID 19057193, PMID 19106243, PMID 19150856, PMID 19188252, PMID 19321567, PMID 19588121, PMID 19828686, PMID 20070283, PMID 20150565, PMID 20304764, PMID 20484484, PMID 20519362, PMID 20724580, PMID 20739716, PMID 20844186, PMID 21076294, PMID 21389329, PMID 21430254, PMID 21527663, PMID 21529326, PMID 21606874, PMID 21798089
R01AG018311 (1), R01AG030070 (1), R01AR049877 (1), R21AR074138 (1)